| Abstrakt: |
A study conducted by the University of Tehran explores the field of bioinformatics and its application in personalized precision medicine, specifically in cancer treatment. The researchers developed a personalized drug combination protocol using data from breast cancer patients, healthy individuals, and various drugs. By comparing individual gene expression patterns and drug signatures, personalized drug combinations were identified, including the repurposing of existing drugs. The study suggests that these personalized drug combinations could offer more effective treatment options for cancer patients. [Extracted from the article] |
